GLOBUS MEDICAL INC — États financiers trimestriels (NYSE:GMED)

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Market Capitalization 11.12 B
Employee 6 000
Founded 2003
CEO Keith Pfeil
Website www.globusmedical.com
Headquarter Delaware, United States
FIGI BBG002V87SD0
Industry Dispositifs Médicaux

Chiffre d'affaires total

Résultat net

Bénéfice par action de base (BPA de base)

Dette totale

Flux de trésorerie disponible

Trésorerie et équivalents de trésorerie

ratio cours/bénéfice

20.13

ratio cours/chiffre d'affaires

3.8

Globus Medical, Inc. Class A Common Stock

Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.

GMED

Financials

Globus Medical, Inc. Class A Common Stock

Nouvelles

Here's Why You Should Hold Avantor Stock in Your Portfolio for Now

Teladoc Health Broadens Virtual Care Reach Through Walmart Platform

HealthEquity Stock Gains as Q1 Earnings Top Estimates, Revenues Up Y/Y

GMED's Robotics Leasing Shift Could Build Recurring Revenue

Reasons to Retain TransMedics Stock in Your Portfolio for Now

Natera to Launch Enhanced Panorama NIPT for Low Fetal Fractions

Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?

Is This the Right Time to Keep HSIC Stock in Your Portfolio?

Myriad Genetics' Upcoming Prolaris + AI Test Debut May Lift Its Stock

GMED Growth Drivers After NuVasive and What Q1 Signals

Looking for a Growth Stock? 3 Reasons Why Globus Medical (GMED) is a Solid Choice

Globus Medical (GMED) Upgraded to Strong Buy: Here's What You Should Know